A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mellitus

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/08 → 9/30/12

Funding

  • TKL Research Inc: $22,351.00